PSTV — Stock activity · TradeandTellPSTV
PSTV
$3.87+$0.22 (+6.03%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$2.90 – $23.43
5% from low
Held by traders on TradeandTell
No one on the platform currently holds PSTV.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PSTV as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|
| 2026-04-02 | 1-for-25reverse |
| 2023-05-01 | 1-for-15reverse |
| 2019-08-06 | 1-for-50reverse |
| 2018-05-24 | 1-for-10reverse |
| 2016-05-12 | 1-for-15reverse |
Recent trades on TradeandTell
No one on the platform has traded PSTV yet.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $6M | +20.1% | $-3.98 | $-3.99–$-3.97 | — | 3 |
| 2027 | $20M | +223.0% | $-2.36 | $-2.49–$-2.22 | — | 3 |
| 2028 | $46M | +126.0% | $-0.32 | $-0.62–$-0.05 | — | 3 |
| 2029 | $121M | +166.1% | $1.67 | $1.06–$2.35 | 2.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-05-15 | $-0.95 | $-1.05 | -10.5% |
| 2026-03-12 | $-0.80 | $-0.83 | -4.2% |
| 2025-10-30 | $-0.02 | $-0.04 | -100.0% |
| 2025-08-14 | $-0.09 | $-0.01 | +88.9% |
| 2025-05-30 | $-0.25 | $-0.56 | -125.7% |
| 2025-03-27 | $-0.51 | $-0.67 | -31.4% |
| 2024-11-14 | $-0.56 | $-0.37 | +34.2% |
| 2024-08-14 | $-0.53 |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| PSTVPlus Therapeutics, Inc. | $3.87 | -3.25% | $9M | — |
| ADTXAditxt, Inc. | $0.00 | -20.00% | $2M | — |
| BXRXQBaudax Bio, Inc. | $0.00 | +0.00% | $4359 | — |
| EDSAEdesa Biotech, Inc. | $5.43 | +2.45% | $52M | — |
| MTVAMetaVia Inc. | $1.46 | -0.68% |
| PHIOPhio Pharmaceuticals Corp. | $1.09 | +0.93% | $13M | — |
| RKTOHoth Therapeutics, Inc. | $0.77 | -2.84% | $17M | — |
Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
- Form 4 filed Jul 1, 2026↗
- Form 4 filed Jul 1, 2026↗
- Form 4 filed Jul 1, 2026↗
- Form 4 filed Jul 1, 2026↗
- Form 4 filed Jul 1, 2026↗
- Form 4 filed Jul 1, 2026↗
- Form 4 filed Jul 1, 2026↗
- Form 4 filed May 18, 2026↗
- Form 4 filed May 18, 2026↗
- Form 4 filed May 18, 2026↗
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.